Advances in surgical and medical treatment have dramatically improved the prognosis of cardiovascular complications in Marfan's syndrome.
Answers are grounded in this paper and cite their sources.
May inform updated Marfan syndrome management; extends prior syntheses but leaves open need for prospective validation.
Marfan's syndrome is an inherited disorder of connective tissue, caused by mutations in the fibrillin-1 gene located on chromosome 15. Diagnosis is still based on a combination of major and minor clinical features. Prognosis is mainly determined by the cardiovascular complications. Advances in surgical and medical treatment for these complications have dramatically improved the prognosis of the syndrome.
No takes yet. Share an insight, caveat, or question.
Nollen et al. (2002) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: